The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
QRM Process
Pharmaceutical Manufacturing: Is It the Antithesis of Creative Destruction?
PAT and QbD can only move forward if the industry sheds its habit of QbA (i.e., quality by analysis)
Girish Malhotra
July 16, 2008
About the Author
Girish Malhotra
PE
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates
SIGN UP
Related
Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
Sponsored
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Trending
WuXi AppTec and WuXi Biologics get reprieve in latest version of BIOSECURE Act
Lilly to build $5B manufacturing facility in Virginia, near Richmond
GSK to invest $30B in US R&D, manufacturing over five years
Recommended
OnTrak Wireless: Total Bearing Health Solution
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Attindas Hygienic Partners Avoids Catastrophic Failure with Remote Lubrication
Load More Content